Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment Due to AD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Early research (Phase 1)Study completedNCT02221622
What this trial is testing

Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of Southern California 24
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07741526
What this trial is testing

Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD)

Who this might be right for
Alzheimer´s Disease
Arctic Therapeutics 33
Testing effectiveness (Phase 2)UnknownNCT03806478
What this trial is testing

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
DementiaAlzheimer Disease 1Alzheimer Disease 2+1 more
Aphios 60
Not applicableStudy completedNCT05504811
What this trial is testing

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

Who this might be right for
Cognitive DysfunctionDementia, Mild
Flint Rehabilitation Devices, LLC 31
Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Testing effectiveness (Phase 2)Study completedNCT02423200
What this trial is testing

Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Alzheimer's Disease
EIP Pharma Inc 16
Testing effectiveness (Phase 2)Study completedNCT04498650
What this trial is testing

Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD

Who this might be right for
Early Alzheimers DiseaseMild Cognitive Impairment Due to AD
Vivoryon Therapeutics N.V. 259
Not applicableEnrolling By InvitationNCT07672977
What this trial is testing

Home-Based Closed-Loop Auditory Stimulation to Enhance Slow-Wave Activity in MCI Due to Alzheimer's Disease: A Proof-of-Concept Study

Who this might be right for
MCI-AD, Early Stage Alzheimer's DiseaseAlzheimer s DiseaseMild Cognitive Impairment (MCI) Amnestic+2 more
Bitbrain 30
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05399888
What this trial is testing

Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease Dementia
Biogen 416
Not applicableLooking for participantsNCT07786116
What this trial is testing

The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions

Who this might be right for
PARKINSON DISEASE (Disorder)ParkinsonParkinson Disease+19 more
University of Cambridge 215
Testing effectiveness (Phase 2)Study completedNCT04602624
What this trial is testing

Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Dementia
Supernus Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT04191486
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Mild Cognitive Impairment
FUJIFILM Toyama Chemical Co., Ltd. 221
Large-scale testing (Phase 3)Looking for participantsNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Not applicableLooking for participantsNCT07224607
What this trial is testing

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Who this might be right for
Alzheimer's Disease
Cedars-Sinai Medical Center 45
Not applicableLooking for participantsNCT07089303
What this trial is testing

Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Chinese PLA General Hospital 750
Not applicableUnknownNCT06508268
What this trial is testing

Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseMCI Due to ADDementia Alzheimers
Hanze University of Applied Sciences Groningen 208
Next Page